Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CKD-342 for perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• CKD-342

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED